BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1039 related articles for article (PubMed ID: 28663251)

  • 21. Gut microbial taxa as potential predictive biomarkers for acute coronary syndrome and post-STEMI cardiovascular events.
    Gao J; Yan KT; Wang JX; Dou J; Wang J; Ren M; Ma J; Zhang X; Liu Y
    Sci Rep; 2020 Feb; 10(1):2639. PubMed ID: 32060329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes Pathogenesis.
    Li D; Kirsop J; Tang WH
    Curr Diab Rep; 2015 Sep; 15(9):63. PubMed ID: 26208694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
    Haissman JM; Haugaard AK; Ostrowski SR; Berge RK; Hov JR; Trøseid M; Nielsen SD
    BMC Infect Dis; 2017 Jun; 17(1):445. PubMed ID: 28645263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.
    Kaysen GA; Johansen KL; Chertow GM; Dalrymple LS; Kornak J; Grimes B; Dwyer T; Chassy AW; Fiehn O
    J Ren Nutr; 2015 Jul; 25(4):351-6. PubMed ID: 25802017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis.
    Zhuang R; Ge X; Han L; Yu P; Gong X; Meng Q; Zhang Y; Fan H; Zheng L; Liu Z; Zhou X
    Obes Rev; 2019 Jun; 20(6):883-894. PubMed ID: 30868721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function.
    Sanchez-Gimenez R; Peiró ÓM; Bonet G; Carrasquer A; Fragkiadakis GA; Bulló M; Papandreou C; Bardaji A
    Front Cardiovasc Med; 2022; 9():1000815. PubMed ID: 36211587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer.
    Oellgaard J; Winther SA; Hansen TS; Rossing P; von Scholten BJ
    Curr Pharm Des; 2017; 23(25):3699-3712. PubMed ID: 28641532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating Gut Microbiota Metabolite Trimethylamine N-Oxide (TMAO) and Changes in Bone Density in Response to Weight Loss Diets: The POUNDS Lost Trial.
    Zhou T; Heianza Y; Chen Y; Li X; Sun D; DiDonato JA; Pei X; LeBoff MS; Bray GA; Sacks FM; Qi L
    Diabetes Care; 2019 Aug; 42(8):1365-1371. PubMed ID: 31332027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults.
    Fretts AM; Hazen SL; Jensen P; Budoff M; Sitlani CM; Wang M; de Oliveira Otto MC; DiDonato JA; Lee Y; Psaty BM; Siscovick DS; Sotoodehnia N; Tang WHW; Lai H; Lemaitre RN; Mozaffarian D
    JAMA Netw Open; 2022 May; 5(5):e2213242. PubMed ID: 35594043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Gut Microbial Metabolite Trimethylamine N-Oxide and Hypertension Risk: A Systematic Review and Dose-Response Meta-analysis.
    Ge X; Zheng L; Zhuang R; Yu P; Xu Z; Liu G; Xi X; Zhou X; Fan H
    Adv Nutr; 2020 Jan; 11(1):66-76. PubMed ID: 31269204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke.
    Zhang J; Wang L; Cai J; Lei A; Liu C; Lin R; Jia L; Fu Y
    J Neuroimmunol; 2021 May; 354():577526. PubMed ID: 33647820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.
    Tang WH; Wang Z; Li XS; Fan Y; Li DS; Wu Y; Hazen SL
    Clin Chem; 2017 Jan; 63(1):297-306. PubMed ID: 27864387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
    Mueller DM; Allenspach M; Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A
    Atherosclerosis; 2015 Dec; 243(2):638-44. PubMed ID: 26554714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria.
    Winther SA; Øllgaard JC; Hansen TW; von Scholten BJ; Reinhard H; Ahluwalia TS; Wang Z; Gæde P; Parving HH; Hazen S; Pedersen O; Rossing P
    PLoS One; 2021; 16(3):e0244402. PubMed ID: 33657115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiota-dependent trimethylamine N-oxide and all-cause mortality: Findings from an updated systematic review and meta-analysis.
    Farhangi MA
    Nutrition; 2020 Oct; 78():110856. PubMed ID: 32592979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of serum trimethylamine N-oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort.
    Byrd DA; Zouiouich S; Karwa S; Li XS; Wang Z; Sampson JN; Loftfield E; Huang WY; Hazen SL; Sinha R
    Cancer; 2024 Jun; 130(11):1982-1990. PubMed ID: 38285606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Gut Microbiota-Related Metabolites and Type 2 Diabetes in Two Puerto Rican Cohorts.
    Sawicki CM; Pacheco LS; Rivas-Tumanyan S; Cao Z; Haslam DE; Liang L; Tucker KL; Joshipura K; Bhupathiraju SN
    Nutrients; 2024 Mar; 16(7):. PubMed ID: 38612993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis.
    Guasti L; Galliazzo S; Molaro M; Visconti E; Pennella B; Gaudio GV; Lupi A; Grandi AM; Squizzato A
    Intern Emerg Med; 2021 Jan; 16(1):201-207. PubMed ID: 32779113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of gut-related metabolites with outcome in acute heart failure.
    Israr MZ; Bernieh D; Salzano A; Cassambai S; Yazaki Y; Heaney LM; Jones DJL; Ng LL; Suzuki T
    Am Heart J; 2021 Apr; 234():71-80. PubMed ID: 33454370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review and meta-analysis of the gut microbiota-dependent metabolite trimethylamine N-oxide with the incidence of atrial fibrillation.
    Yang WT; Yang R; Zhao Q; Li XD; Wang YT
    Ann Palliat Med; 2021 Nov; 10(11):11512-11523. PubMed ID: 34872276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.